1. Boiardi A, Silvani A, Milanesi I, Botturi M, Broggi G (1991) Primary glial tumor patients treated by combining cis-platin and etoposide. J Neuro-oncol 11: 165–170
2. Braybrooke JP, Levitt NC, Joel S, Davis T, Madhusudan S, Turley H, Wilner S, Harris AL, Talbot DC (2003) Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIα expression. Clin Cancer Res 9: 4682–4688
3. Buckner JC, Brown LD, Cascino TL, Gerstner JB, Krook JE, Westberg MW, Wiesenfeld M, O'Fallon JR, Scheithauer B (1990) Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma. J Neuro-oncol 9: 249–254
4. Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold Jr C (1994) Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013–2021
5. Dingemans AM, Witlox MA, Stallaert RA, Van der Valk P, Postmus PE, Giaccone G (1999) Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res 5 (8): 2048–2058